← Back to Prospects

Kanvas Biosciences

HotNo broker found

$48M Series A, no broker, CEO lives 5 miles from Adam

Company Info

Industry
Biotech / Microbiome Therapeutics
Location
Princeton, NJ (also SF labs)
Employees
39+37.9%

Office Situation

Address
Monmouth Junction, NJ area (Princeton R&D + corporate)
Current Space
Not disclosed (R&D lab + office)
Lease Expiry
Not found

Funding

Total Raised
$76.4M
Last Round
$48M Series A
Round Date
May 1, 2026

Decision Makers

Matthew P. ChengPrimary2nd (from Shubh)
Co-Founder & CEO
Monmouth Junction, NJ
Infectious diseases physician turned entrepreneur. Also Investment Committee member at Alumni Ventures.

Qualification

Fast-growing microbiome biotech with $48M fresh capital. Princeton is R&D/corporate HQ (GMP in SF). Scaling to clinical trials = more lab+office needed. CEO lives in Monmouth Junction, 5 mi from Adam's East Brunswick office. No existing broker relationship found.

Broker Intel

No broker found

No broker relationship found in press releases or lease announcements

Warm Intro Paths

  • 📍
    Geographic proximity — Adam's office (East Brunswick) is 5 miles from CEO's home (Monmouth Junction)LinkedIn
  • 🏢
    Adam markets Princeton Corporate Center space on Route 1 — natural expansion target for KanvasCBRE listing
  • 📅
    BioNJ AI & Digital Health Day (Oct 23, 2026) — Kanvas fits as spatial biology + therapeutics companyBioNJ

Sources

ClaimSource
$48M Series A (May 2026), co-led by DCVC + Lions Capital, Gates FoundationPRNewswire
Labs in Princeton, NJ and San Francisco, CAKanvas About page
Princeton is R&D/corporate; GMP manufacturing in SFKanvas News
CEO lives in Monmouth Junction, NJLinkedIn profile
H-1B filings confirm NJ locationMyVisaJobs
Currently hiring Head of Quality AssuranceCareers page

Events & Touchpoints

  • Princeton University Friend CenterKanvas fits as spatial biology + therapeutics company
  • AI-Driven Drug Discovery SummitNov 3, 2026
    Princeton, NJKanvas uses AI for microbiome drug discovery

Draft Outreach Message

Hi Matt — Congratulations on the $48M raise! That's a huge milestone for Kanvas. I work with Adam Englander at CBRE on the Princeton market and wanted to connect. As you scale toward clinical trials, your lab space needs will change fast — we've helped several biotech companies in the Princeton corridor plan their next phase of growth (both lab and office). I'd love to learn more about where Kanvas is headed and share what we're seeing in the market. Would a 15-minute call be useful? — Carly